Neuren Pharmaceuticals | NEU - Assets

Stock Price
12.35
Daily Change
-0.44 -3.44%
Monthly
-1.04%
Yearly
-2.22%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD342.86M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Clinuvel Pharmaceuticals AUD 269.7M 2.05M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Genetic Signatures AUD 49.04M 5.59M Dec/2025
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
Medical Developments International AUD 63.57M 2.83M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organon & Co USD 13B 129M Mar/2026
Paradigm Biopharmaceuticals AUD 23.15M 1.42M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Starpharma Holdings AUD 26.17M 746K Dec/2025
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026